Immix Biopharma, Inc.(IMMX:US)
Market Cap$568.1M
Key Metrics
Price$7.98
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$39.92M
EBITDA (TTM)-$41.33M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$225.49M
Total Assets$239.11M
Net Assets$228.92M
Total Debt$1M
Key Metrics
Price$7.98
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$39.92M
EBITDA (TTM)-$41.33M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$225.49M
Total Assets$239.11M
Net Assets$228.92M
Total Debt$1M
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | - | - | - | - | - | - | - | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $12.46M | $10.8M | $10.89M | $7.66M | $6.72M | - | - | - | - | - | - | - | $3.72M | $2.52M | $3.79M | $1.53M | $1.56M | $1.33M | $598.34K | $347.99K | $243.17K | $162.52K | $153.59K | $91.24K | |
| Research and Development | $5.33M | $5.98M | $5.73M | $4.58M | $3.97M | - | - | - | - | - | - | - | $2.21M | $1.32M | $2.26M | $695.94K | $607.75K | $629.53K | $9.24K | $29.69K | $62.76K | $24.84K | $83.33K | $44.96K |
| Selling, General, and Administrative | $7.12M | $4.82M | $5.17M | $3.08M | $2.75M | - | - | - | - | - | - | - | $1.51M | $1.2M | $1.53M | $837.44K | $953.2K | $700.51K | $589.1K | $318.3K | $180.4K | $137.68K | $70.26K | $46.28K |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$12.46M | -$10.8M | -$10.89M | -$7.66M | -$6.72M | - | - | - | - | - | - | - | -$3.72M | -$2.52M | -$3.79M | -$1.53M | -$1.56M | -$1.33M | -$598.34K | -$347.99K | -$243.17K | -$162.52K | -$153.59K | -$91.24K |
| $913.66K | $717.17K | $216.71K | $84.54K | $104.06K | - | - | - | - | - | - | - | $128.85K | $27.89K | $0 | $0 | -$109 | -$388 | -$22.16M | -$53.94K | $36.14K | -$852.54K | -$599.7K | -$23.36K | |
| Non-Operating Interest Income | $913.66K | $717.17K | $216.71K | $84.54K | $104.06K | - | - | - | - | - | - | - | $128.85K | $27.89K | - | $0 | $0 | $0 | - | - | - | - | - | - |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | $0 | $0 | $0 | $0 | $109 | $388 | $44.51K | $53.94K | $53.87K | $27.54K | $24.69K | $23.37K |
| Other Income/Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -$22.11M | $0 | $90K | -$825K | -$575.01K | $8 |
Income Before Tax | -$11.54M | -$10.09M | -$10.68M | -$7.58M | -$6.61M | - | - | - | - | - | - | - | -$3.59M | -$2.49M | -$3.79M | -$1.53M | -$1.56M | -$1.33M | -$22.75M | -$401.93K | -$207.03K | -$1.02M | -$753.29K | -$114.6K |
Income Tax | $14.32K | $0 | $11.27K | $7.72K | $8.91K | $9.82K | $10.79K | $11.14K | $10.27K | $8.84K | $8.09K | $6.81K | $6.35K | $5.17K | $5.26K | $1.67K | $1.72K | $1.62K | $1.48K | $1.34K | $1.61K | $1.59K | $12.29K | $1.72K |
Net Income | -$11.56M | -$10.09M | -$10.69M | -$7.59M | -$6.62M | - | - | - | - | - | - | - | -$3.6M | -$2.5M | -$3.8M | -$1.54M | -$1.56M | -$1.33M | -$22.76M | -$403.27K | -$208.64K | -$1.02M | -$765.58K | -$116.32K |
Minority Interests | - | - | $0 | $0 | $0 | - | - | - | - | - | - | - | $22K | $18.37K | - | $0 | $0 | $0 | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$11.56M | -$10.09M | -$10.69M | -$7.59M | -$6.62M | - | - | - | - | - | - | - | -$3.58M | -$2.48M | -$3.8M | -$1.54M | -$1.56M | -$1.33M | -$22.76M | -$403.27K | -$208.64K | -$1.02M | -$765.58K | -$116.32K |
Shares Outstanding (Basic) | 63.77M | 55.37M | - | 31.93M | 29.98M | 29.7M | - | 29.42M | 28.79M | 23.44M | - | 18.58M | 15.04M | 13.9M | - | 13.92M | 13.88M | 13.83M | - | 7.2M | 8.77M | 8.77M | - | - |
Shares Outstanding (Diluted) | 63.77M | 55.37M | - | 31.93M | 29.98M | 29.7M | - | 29.42M | 28.79M | 23.44M | - | 18.58M | 15.04M | 13.9M | - | 13.92M | 13.88M | 13.83M | - | 7.2M | 8.77M | 8.77M | - | - |
EPS (Basic) | -$0.18 | -$0.18 | - | -$0.24 | -$0.22 | -$0.15 | - | -$0.24 | -$0.15 | -$0.22 | - | -$0.23 | -$0.24 | -$0.18 | - | -$0.11 | -$0.11 | -$0.10 | - | -$0.056 | -$0.024 | -$0.12 | - | - |
EPS (Diluted) | -$0.18 | -$0.18 | - | -$0.24 | -$0.22 | -$0.15 | - | -$0.24 | -$0.15 | -$0.22 | - | -$0.23 | -$0.24 | -$0.18 | - | -$0.11 | -$0.11 | -$0.10 | - | -$0.056 | -$0.024 | -$0.12 | - | - |
EBIT | -$12.46M | -$10.8M | -$10.89M | -$7.66M | -$6.72M | - | - | - | - | - | - | - | -$3.72M | -$2.52M | -$3.79M | -$1.53M | -$1.56M | -$1.33M | -$22.71M | -$347.99K | -$153.17K | -$987.52K | -$728.6K | -$91.23K |
EBITDA | -$12.33M | -$10.67M | -$10.8M | -$7.53M | -$6.64M | - | - | - | - | - | - | - | -$3.72M | -$2.52M | -$3.79M | -$1.53M | -$1.56M | -$1.33M | -$597.72K | -$347.37K | -$242.55K | -$161.91K | -$728.01K | -$90.65K |